Abstract
COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Coronaviruses
Title:Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions
Volume: 2 Issue: 11
Author(s): Ram Kumar Dhaked*
Affiliation:
- Biotechnology Division, Defence Research & Development Establishment, Ministry of Defence, Govt. of India, Jhansi Road, Gwalior - 474002,India
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Abstract: COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Export Options
About this article
Cite this article as:
Dhaked Kumar Ram *, Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions, Coronaviruses 2021; 2 (11) : e310821191744 . https://dx.doi.org/10.2174/2666796702666210223155638
DOI https://dx.doi.org/10.2174/2666796702666210223155638 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Repositioning of Drugs as a Promising Strategy to Fight COVID-19
Coronaviruses Comparative Safety Assessment Study for Drospirenone Induced Gallbladder Diseases Using the Adverse Drug Reaction Database of USA, Europe, and Canada
Current Drug Safety Improved Prediction of Lysine Acetylation by Support Vector Machines
Protein & Peptide Letters Positive Aspects, Negative Aspects and Challenges Associated with Stem Cell Therapy for COVID - 19: A Mini-review
Current Stem Cell Research & Therapy <i>In Silico</i> Identification of Potential Inhibitors of SARS-CoV-2 Papain-like Protease From Natural Sources: A Natural Weapon to Fight COVID-19
Coronaviruses A Comparative Study of SARS, MERS with COVID-19
Coronaviruses Progress in Computational Approach to Drug Development Against SARS
Current Medicinal Chemistry Impact of COVID-19 on Mental Dimension of Health: A Sensitive Issue to be Addressed at the Earliest
Current Psychiatry Research and Reviews Can Probiotics Cure Inflammatory Bowel Diseases?
Current Pharmaceutical Design Emerging Evidence for Neuropsycho-Consequences of COVID-19
Current Neuropharmacology Invited Editorial: MERS-CoV An Emerging Viral Zoonotic Disease: Three Years After and Counting
Recent Patents on Anti-Infective Drug Discovery Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review
CNS & Neurological Disorders - Drug Targets Immunomodulatory Effects of <i>Allium sativum</i> L. and its Constituents against Viral Infections and Metabolic Diseases
Current Topics in Medicinal Chemistry The Interplay Among Epilepsy, Parkinson’s Disease and Inflammation: Revisiting the Link through Ca<sup>2+</sup>/cAMP Signalling
Current Neurovascular Research The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
Current Neurovascular Research Recent Advances in Computational Studies on Influenza A Virus M2 Proton Channel
Mini-Reviews in Medicinal Chemistry <i>In Silico</i> Identification of New Anti-SARS-CoV-2 Agents from Bioactive Phytocompounds Targeting the Viral Spike Glycoprotein and Human TLR4
Letters in Drug Design & Discovery Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy
Current Medicinal Chemistry Medicinal Importance, Pharmacological Activities and Analytical Aspects of a Flavonoid Glycoside ‘Nicotiflorin’ in the Medicine
Drug Metabolism and Bioanalysis Letters Persistent Hiccups as an Atypical Initial Presentation of COVID-19: A Case Report
Infectious Disorders - Drug Targets